INTRODUCTION
Helicobacter pylori (H. pylori) is a gram-negative anaerobic spiral-shaped rods. It develops several mechanisms for its survival and replication in the acidic environment of the stomach. H. pylori synthesizes urease enzyme which catalyze the hydrolysis of urea to ammonia, which in turn decreases the stomach pH and produces a neutral environment around the bacteria [1]. H. pylori was reported globally to colonizes the gastric mucosal lining of ~50% to 60% of the world population, with increased prevalence in those patients with other inflammatory diseases including autoimmune, vascular and skin diseases [2] . In Egypt, prevalence of H. pylori is much higher in the healthy asymptomatic population both in adults and in pediatric populations. Low socioeconomic status, low body mass index, living in rural areas and low educational status were multiple risk factors for the acquisition of H. pylori in most of the Egyptian studies [3] . Chronic obstructive pulmonary disease (COPD) represents an important public health challenge and is a major cause of chronic morbidity and mortality worldwide [4] . Gastro-oesophageal reflux disease (GERD) is one of the most common causes of chronic cough and a potential risk factor for COPD exacerbation [5, 6] . GERD is a relatively common condition, affecting ~10 to 29% of the western population [7] . Gastro-oesophageal reflux (GER) can heighten bronchial reactivity and micro-aspiration [8] . Abnormal GER was associated to lung diseases [9] . Moreover, most COPD patients have flat diaphragm and increased intraabdominal and negative intra-thoracic pressure, which could aggravate GER [10] . GERD is more common in patients with COPD than in those without COPD [11] . Also, it has been suggested that an increase in the frequency of COPD exacerbation can be associated with GERD [12] . The possible mechanisms for the relationship between H. pylori and COPD might be the systemic effect of certain gastrointestinal peptides as gastrin, somatostatin, and cytokine release or due to direct injury and chronic inflammation of airways due to aspiration and/or inhalation, most probably activation of inflammatory mediators by H. pylori is the pathogenic mechanism of extragastric manifestations of H. pylori infection [13] .The aim of our work was to estimate impact of H. pylori infection on the severity of COPD and clarifying a role for H. pylori infection in COPD exacerbation.
PATIENTS AND METHODS

Study design and settings
This observative prospective study was conducted at Tropical medicine, Internal medicine and Chest departments, Zagazig university hospitals, Egypt, through a twelve months period from October 2017 to October 2018.
Target population
Out of 300 well controlled COPD patients attending our outpatient clinics, one hundred forty-two patients fulfilling inclusion and exclusion criteria were randomly chosen to participate in this study.
Inclusion criteria
COPD patients diagnosed according to the Global Initiative for Chronic Obstructive Lung Disease guidelines (14) . For patients with airway obstruction according to the American Thoracic Society/The European Respiratory Society (ATS/ ERS) guidelines (Forced expiratory volume (FEV1) at the end of the first and second/Forced vital capacity (FVC) <70%), detection of COPD severity was performed according to the following criteria ; stage 1: FEV1 ≥80% predicted, stage 2: 50% ≤FEV1 <80% predicted, stage 3: 30% ≤FEV1 <50% predicted and Stage 4: FEV1 <30% predicted.
Exclusion criteria
Those patients with asthma, known peptic ulcers, acute exacerbation of COPD, used antibiotics within and PPIs within the last month, histamine-2-receptor antagonists within the last week, an antacid within the last 24 hours and those having H. pylori eradication treatment within the last 6 months were excluded from beginning of the study.
Patients classification
According to presence of H. pylori, participants were classified into two groups; group 1 which included 72 COPD patients with positive H. pylori infection and group 2 which included 70 COPD patients with negative H. pylori infection. 
Study tools
RESULTS
There were no significant differences between both groups regarding mean age, gender, smoking pattern and the prevalence of comorbidities. (Table 1 (Table 2) . High significant statistical differences were found between both groups regarding; FEV1, FVC, PH, PaO2, which were lower in group 1 when compared to group 2. While CRP, CAT score, PCO2, HCO3 were significantly higher in group 1 (Table 3) .Moreover, there was a high significant statistical difference in the severity of COPD which was higher in group 1 when compared to group 2 where the sever and very sever COPD cases were more abundant in group 1 (Table 4) . At number of COPD exacerbation (1-3), COPD patients with positive H. pylori infection (group 1) had less frequent exacerbations than those of group 2 (43% Vs 77 %) respectively, while at number of exacerbation (4-7), group 1 has more frequent exacerbation than those of group 2 (57% Vs 21.5%) respectively with high significant statistical difference (Table 5) . Regarding COPD severity according to their post-bronchodilator FEV1%, patients in the present research were classified into; mild COPD {19 patients (13.4%)}, moderate COPD {77 patients (54.2%)}, Severe COPD {33 patients (23.2%)} and very sever COPD {13 patients (9.2%)}. Spirometry parameters in both groups showed that FEV1 and FVC were significantly lower in H. pylori positive group when compared with these of H. pylori negative status. There was a high significant statistical difference in COPD severity in group 1 when compared with group 2, evident with more cases of sever and very sever COPD cases in group 1.
The CAT and FEV1 are both reliable methods for assessing treatment response and progression of disease severity in COPD patients [33] . Our study showed significant statistical difference positive correlation between CAT and COPD severity. This finding agreed with Hassan et al., (2012) who determined the relationship between CAT scores and severity of airflow obstruction in stable COPD patients. In their study, the correlation between mean FEV1%predicted and mean score of CAT groups 1, 2, 3, and 4 was statistically significant. In our study, CAT score was 20.6 ±9. (27) .
CONCLUSION
This study clearly demonstrated that H. pylori infection may play a role in COPD initiation and exacerbation in predisposed patients, due to high prevalence of both H. pylori and COPD. More randomized controlled studies are needed before confirming this interplay as a tight relation of just co-association.
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